Shauna Correia

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Flibanserin, a drug with mixed effects on serotonergic and dopami-nergic neurotransmitter systems, has recently been recommended for FDA approval, albeit with many restrictions, for the treatment of low sexual desire in premenopausal women. The sexual side effects of antide-pressants with at least partially known mechanisms of action indicate that(More)
  • 1